|
RBM27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.994900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.240400E-02 |
| Normal-vs-Stage2 |
1.561190E-01 |
| Normal-vs-Stage3 |
1.151950E-04 |
| Normal-vs-Stage4 |
8.10400000000877E-05 |
| Stage1-vs-Stage2 |
9.052200E-01 |
| Stage1-vs-Stage3 |
2.551900E-02 |
| Stage1-vs-Stage4 |
2.180400E-02 |
| Stage2-vs-Stage3 |
2.418800E-01 |
| Stage2-vs-Stage4 |
1.786380E-01 |
| Stage3-vs-Stage4 |
7.737400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.840580E-03 |
| Normal-vs-AfricanAmerican |
6.37329999997327E-07 |
| Normal-vs-Asian |
8.973600E-01 |
| Caucasian-vs-AfricanAmerican |
6.064200E-03 |
| Caucasian-vs-Asian |
3.285400E-01 |
| AfricanAmerican-vs-Asian |
2.265600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.961100E-04 |
| Normal-vs-Female |
3.460600E-03 |
| Male-vs-Female |
8.473400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.095400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.629530E-02 |
| Normal-vs-Age(61-80Yrs) |
2.157500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.810200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.470820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.365800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.462000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.715420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.133400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.792200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.292400E-01 |
| Normal-vs-Grade 2 |
3.989700E-02 |
| Normal-vs-Grade 3 |
1.357920E-03 |
| Normal-vs-Grade 4 |
2.33059999998897E-06 |
| Grade 1-vs-Grade 2 |
5.984000E-01 |
| Grade 1-vs-Grade 3 |
2.166800E-01 |
| Grade 1-vs-Grade 4 |
2.995600E-02 |
| Grade 2-vs-Grade 3 |
1.348800E-01 |
| Grade 2-vs-Grade 4 |
1.482610E-03 |
| Grade 3-vs-Grade 4 |
2.885600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.063800E-01 |
| Normal-vs-ccB subtype |
2.444700E-04 |
| ccA subtype-vs-ccB subtype |
9.761300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.342100E-03 |
| Normal-vs-N1 |
2.492400E-02 |
| N0-vs-N1 |
4.777000E-01 |
|
|
